WBH Advisory Inc. Acquires 174 Shares of The Clorox Company (NYSE:CLX)

WBH Advisory Inc. boosted its holdings in The Clorox Company (NYSE:CLX) by 12.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,522 shares of the company’s stock after buying an additional 174 shares during the period. WBH Advisory Inc.’s holdings in Clorox were worth $247,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. State Street Corp lifted its position in Clorox by 3.1% in the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock valued at $1,332,947,000 after acquiring an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC lifted its position in Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after acquiring an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after buying an additional 33,970 shares during the period. Stifel Financial Corp lifted its holdings in shares of Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after buying an additional 37,967 shares during the period. Finally, Van ECK Associates Corp lifted its holdings in shares of Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after buying an additional 31,510 shares during the period. 78.53% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CLX. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Barclays increased their price target on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Wells Fargo & Company increased their price target on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. DA Davidson lowered their price target on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $158.21.

Clorox Trading Down 1.9 %

Shares of CLX stock opened at $147.91 on Tuesday. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The firm has a market capitalization of $18.31 billion, a PE ratio of 40.41, a PEG ratio of 2.52 and a beta of 0.42. The stock has a fifty day simple moving average of $159.17 and a two-hundred day simple moving average of $159.61.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the business earned $2.16 earnings per share. On average, analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.